Call Options Transactions Made in Q3 2022 in Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO) during Q3 2022. The information is specifically focused on institutions that hold call options of BridgeBio Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
BUY
|
CALL |
39.1KNew |
$310K - $483K
|
39.1K
$1.12M
|
|
|
Nov 14, 2022
Q3 2022
|
Balyasny Asset Management LLC
Chicago, IL |
BUY
|
CALL |
25KNew |
$199K - $309K
|
25K
$713K
|
|
|
Nov 14, 2022
Q3 2022
|
Advent Capital Management
New York, NY |
BUY
|
CALL |
20KNew |
$159K - $247K
|
20K
$571K
|
|
|
Nov 14, 2022
Q3 2022
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
CALL |
-5K- 8.0% |
$39.7K - $61.8K
|
57.5K
$1.64M
|
|
|
Oct 25, 2022
Q3 2022
|
Cutler Group LP
|
SELL
|
CALL |
-7.4K- 68.52% |
$58.8K - $91.5K
|
3.4K
$97K
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-21.7K- 41.97% |
$172K - $268K
|
30K
$856K
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-247K- 91.15% |
$1.96M - $3.05M
|
24K
$685K
|